VolitionRX Ltd
NYSE American:VNRX

  • LAST PRICE
    0.6636
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    0.6400/ 1
  • Ask / Lots
    0.7000/ 2
  • Open / Previous Close
    --- / 0.6636
  • Day Range
    ---
  • 52 Week Range
    0.4301
    1.2300
  • Volume
    ---

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Biotechnology Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
VNRX
VolitionRX Ltd
61.1M
-1.8x
---
ENTX
Entera Bio Ltd
61.1M
-6.4x
---
BIVI
BioVie Inc
60.6M
-0.6x
---
XFOR
X4 Pharmaceuticals Inc
62.4M
-4.3x
---
ALRN
Aileron Therapeutics Inc
62.6M
-0.9x
---
MAIA
Maia Biotechnology Inc
59.5M
-1.7x
---
As of 2024-11-19

Company Information

VolitionRx Limited is a multi-national epigenetics company focused on advancing the science of epigenetics. The Company is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. Through its subsidiaries, it is developing and commercializing blood tests to help diagnose and monitor a range of diseases, including cancers and diseases associated with NETosis, such as sepsis. Its key pillars are Nu.Q Vet, Nu.Q NETs, Nu.Q Discover, Nu.Q Cancer and Capture-PCR. The Nu.Q Vet Cancer Test is commercially available as a cancer screening test in dogs. Nu.Q NETs is monitoring the immune system to save lives. Nu.Q Discover is a complete solution to profiling nucleosomes. Nu.Q Cancer monitoring disease progression, response to treatment and minimal residual disease. Capture-PCRTM is isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection.

Contact Information

Headquarters
1489 West Warm Springs Road, Suite 110HENDERSON, NV, United States 89014
Phone
646-650-1351
Fax
---

Executives

Non-Executive Chairman of the Board
Timothy Still
President, Chief Executive Officer, Director
Cameron Reynolds
Chief Financial Officer, Treasurer
Terig Hughes
Chief Executive Officer of Volition Vet
Salvatore Butera
Chief Executive Officer of Singapore Volition
Jasmine Kway

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$61.1M
Revenue (TTM)
$1.3M
Shares Outstanding
92.1M
VolitionRX Ltd does not pay a dividend.
Beta
1.14
EPS
$-0.36
Book Value
$-0.10
P/E Ratio
-1.8x
Price/Sales (TTM)
47.5
Price/Cash Flow (TTM)
---
Operating Margin
-2,331.90%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.